Neurodegenerative Diseases Can't Hide From Us.
Harnessing Biomarkers and Data-Driven Approaches for Effective Drug Discovery.
stealth /stelTH/
noun: cautious and surreptitious action or movement.
Cutting-edge Research, Proven Approach. Always Moving Forward.
Innovative Solutions for Neurodegenerative Diseases
At Stealth NewCo, we harness data-driven insights to discover small molecule therapeutics targeting neurodegenerative diseases like Alzheimer's, Parkinson's, and ALS, guided by our eminent scientists and advanced biomarker strategies.
Pioneering Biotech Innovations
Transforming Drug Discovery
Our commitment to high throughput screening and biomarker measurement ensures we identify the most active and potent small molecules for effective treatment solutions in neurodegenerative disease management.
Innovative Therapeutics Solutions
Specializing in drug discovery for neurodegenerative diseases using data-driven methodologies and biomarkers.
Biomarker-Driven Research
Utilizing biomarkers to evaluate target engagement in drug discovery for neurodegenerative conditions.
Drug Discovery at the Speed of Thought
Employing high throughput screening to identify effective small molecule therapeutics for neurodegenerative diseases.
Our biologists and medicinal chemists screen thousands and thousand of small molecules to develop robust SAR.
Developing small molecules for targeted treatment strategies in neurodegenerative diseases
Innovative Solutions
Developing therapeutics for neurodegenerative diseases through data-driven research.


Target Engagement
Utilizing biomarkers to measure drug effectiveness and engagement.
High Throughput
Screening strategies to identify potent small molecule candidates.


Drug Discovery
Guiding scientists in developing treatments for neurodegenerative disorders.
Biotech Innovation
We succeed where others fail by cautious and science-driven discovery platforms. We believe our approach will provide breakthroughs in neurodegenerative disease therapeutics.
→
→
→
→
Stealth NewCo's innovative approach is transforming neurodegenerative disease treatment with promising small molecule therapeutics.
Peter F.
Their data-driven methods and focus on biomarkers are truly advancing drug discovery for neurodegenerative diseases.
Ajay S.